UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

High-Dose, Short-Course Levofloxacin for Community-Acquired Pneumonia: A New Treatment Paradigm

Clinical infectious diseases, 2003-09, Vol.37 (6), p.752-760

2003

Volltextzugriff (PDF)

Comparison of the Efficacy and Safety of Oritavancin Front-Loaded Dosing Regimens to Daily Dosing: an Analysis of the SIMPLIFI Trial

Antimicrobial Agents and Chemotherapy, 2011-07, Vol.55 (7), p.3476-3484

2011

Volltextzugriff (PDF)

Telavancin versus Standard Therapy for Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: FAST 2 Study

Antimicrobial Agents and Chemotherapy, 2006-03, Vol.50 (3), p.862-867

2006

Volltextzugriff (PDF)

Telavancin Versus Standard Therapy for Treatment of Complicated Skin and Soft-Tissue Infections Due to Gram-Positive Bacteria

Clinical infectious diseases, 2005-06, Vol.40 (11), p.1601-1607

2005

Volltextzugriff (PDF)

A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI)

Therapeutics and clinical risk management, 2008-02, Vol.4 (1), p.235-244

2008

Volltextzugriff (PDF)

Efficacy of telavancin in patients with specific types of complicated skin and skin structure infections

Journal of antimicrobial chemotherapy, 2012-06, Vol.67 (6), p.1496-1502

2012

Volltextzugriff (PDF)

Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study

BMC infectious diseases, 2005-05, Vol.5 (1), p.43-43, Article 43

2005

Volltextzugriff (PDF)

Tetanus immunity and physician compliance with tetanus prophylaxis practices among emergency department patients presenting with wounds

Annals of emergency medicine, 2004-03, Vol.43 (3), p.305-314

2004

Volltextzugriff (PDF)

Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens

Current medical research and opinion, 2004-04, Vol.20 (4), p.555-563

2004

Volltextzugriff (PDF)

Current Issues in the Management of Bacterial Respiratory Tract Disease: The Challenge of Antibacterial Resistance

The American journal of the medical sciences, 2003-12, Vol.326 (6), p.360-368

Dunbar, Lala M.

2003

Volltextzugriff (PDF)

Staphylococcus aureus Colonization and Strain Type at Various Body Sites among Patients with a Closed Abscess and Uninfected Controls at U.S. Emergency Departments

Journal of clinical microbiology, 2015-11, Vol.53 (11), p.3478-3484

2015

Volltextzugriff (PDF)

Inability of Polymerase Chain Reaction, Pyrosequencing, and Culture of Infected and Uninfected Site Skin Biopsy Specimens to Identify the Cause of Cellulitis

Clinical infectious diseases, 2015-12, Vol.61 (11), p.1679-1687

2015

Volltextzugriff (PDF)

Prevalence and Risk Factor Analysis of Trimethoprim-Sulfamethoxazole— and Fluoroquinolone-Resistant Escherichia coli Infection among Emergency Department Patients with Pyelonephritis

Clinical infectious diseases, 2008-11, Vol.47 (9), p.1150-1158

2008

Volltextzugriff (PDF)

High-Dose, Short-Course Levofloxacin for Community-Acquired Pneumonia: A New Treatment Paradig

Clinical infectious diseases, 2003-09, Vol.37 (6), p.752-760

2003

Volltextzugriff (PDF)

Decision Instrument for the Isolation of Pneumonia Patients With Suspected Pulmonary Tuberculosis Admitted Through US Emergency Departments

Annals of emergency medicine, 2009-05, Vol.53 (5), p.625-632

2009

Volltextzugriff (PDF)

Clevidipine, an Intravenous Dihydropyridine Calcium Channel Blocker, Is Safe and Effective for the Treatment of Patients With Acute Severe Hypertension

Annals of emergency medicine, 2009-03, Vol.53 (3), p.329-338

2009

Volltextzugriff (PDF)

A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI)

Therapeutics and clinical risk management, 2008-03, Vol.2008 (Issue 1), p.235-244

2008

Volltextzugriff (PDF)

Fenoldopam, a Dopamine Agonist, for Hypertensive Emergency: A Multicenter Randomized Trial

Academic emergency medicine, 2000-06, Vol.7 (6), p.653-662

2000

Volltextzugriff (PDF)

Efficacy of a New High Dose, Short Course of Levofloxacin vs Standard 10 Day Therapy for Treatment of Community Acquired Pneumonia (CAP) Caused by Atypical Pathogens

Academic emergency medicine, 2003-05, Vol.10 (5), p.436-436

Dunbar, L. M

2003

Volltextzugriff (PDF)

Randomized, Prospective Trial of Fenoldopam vs Sodium Nitroprusside in the Treatment of Acute Severe Hypertension

Academic emergency medicine, 1995-11, Vol.2 (11), p.959-965

1995

Volltextzugriff (PDF)

High-dose, short-course levofloxacin for community-acquired pneumonia: A new treatment paradigm. Commentary

Clinical infectious diseases, 2003, Vol.37 (6), p.752-763

2003

Volltextzugriff (PDF)

In response

Academic emergency medicine, 1996-06, Vol.3 (6), p.647-648

1996

Volltextzugriff (PDF)

In response

Academic emergency medicine, 1996-06, Vol.3 (6), p.647-648

1996

Volltextzugriff (PDF)

Evaluation of the efficacy and safety of oral nicardipine in treatment of urgent hypertension: A multicenter, randomized, double-blind, parallel, placebo-controlled clinical trial

The American heart journal, 1995-05, Vol.129 (5), p.917-923

1995

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Humans
(22)
Adult
(17)
Biological And Medical Sciences
(17)
Female
(17)
Medical Sciences
(17)
Male
(16)
Middle Aged
(16)
Aged
(11)
Microbiology
(10)
Pharmacology. Drug Treatments
(10)
Adolescent
(8)
Anti-Bacterial Agents - Therapeutic Use
(8)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(8)
Infectious Diseases
(8)
Aged, 80 And Over
(7)
Emergency Medicine
(7)
Community-Acquired Infections - Drug Therapy
(6)
Double-Blind Method
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High-Dose, Short-Course Levofloxacin for Community-Acquired Pneumonia: A New Treatment Paradigm

Comparison of the Efficacy and Safety of Oritavancin Front-Loaded Dosing Regimens to Daily Dosing: an Analysis of the SIMPLIFI Trial

Telavancin versus Standard Therapy for Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: FAST 2 Study

Telavancin Versus Standard Therapy for Treatment of Complicated Skin and Soft-Tissue Infections Due to Gram-Positive Bacteria

A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI)

Efficacy of telavancin in patients with specific types of complicated skin and skin structure infections

Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study

Tetanus immunity and physician compliance with tetanus prophylaxis practices among emergency department patients presenting with wounds

Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens

Current Issues in the Management of Bacterial Respiratory Tract Disease: The Challenge of Antibacterial Resistance

Staphylococcus aureus Colonization and Strain Type at Various Body Sites among Patients with a Closed Abscess and Uninfected Controls at U.S. Emergency Departments

Inability of Polymerase Chain Reaction, Pyrosequencing, and Culture of Infected and Uninfected Site Skin Biopsy Specimens to Identify the Cause of Cellulitis

Prevalence and Risk Factor Analysis of Trimethoprim-Sulfamethoxazole— and Fluoroquinolone-Resistant Escherichia coli Infection among Emergency Department Patients with Pyelonephritis

High-Dose, Short-Course Levofloxacin for Community-Acquired Pneumonia: A New Treatment Paradig

Decision Instrument for the Isolation of Pneumonia Patients With Suspected Pulmonary Tuberculosis Admitted Through US Emergency Departments

Clevidipine, an Intravenous Dihydropyridine Calcium Channel Blocker, Is Safe and Effective for the Treatment of Patients With Acute Severe Hypertension

A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI)

Clevidipine in acute heart failure: Results of the A Study of Blood P ressu r e C o ntrol i n Acute Hear t Failure—A Pil o t Study (PRONTO)

Fenoldopam, a Dopamine Agonist, for Hypertensive Emergency: A Multicenter Randomized Trial

Efficacy of a New High Dose, Short Course of Levofloxacin vs Standard 10 Day Therapy for Treatment of Community Acquired Pneumonia (CAP) Caused by Atypical Pathogens

Randomized, Prospective Trial of Fenoldopam vs Sodium Nitroprusside in the Treatment of Acute Severe Hypertension

High-dose, short-course levofloxacin for community-acquired pneumonia: A new treatment paradigm. Commentary

In response

In response

Evaluation of the efficacy and safety of oral nicardipine in treatment of urgent hypertension: A multicenter, randomized, double-blind, parallel, placebo-controlled clinical trial

Suchergebnisse filtern